[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603204":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":30,"centralContacts":30,"locations":34,"responsibleParty":52,"collaborators":54,"id":57,"slug":30,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":30,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":37,"whyStopped":30,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Epax Norway AS","INDUSTRY",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","1g corn oil capsules",[13],"Dietary Supplement: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Low dose","EXPERIMENTAL","Subjects will receive 2g of Omega 3-9-11 oil",[19,13],"Dietary Supplement: Omega 3-9-11",{"label":21,"type":16,"description":22,"interventionNames":23},"High dose","Subjects will receive 4g of Omega 3-9-11 oil",[19],[25,31],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DIETARY_SUPPLEMENT","Omega 3-9-11","Fish oil capsules containing a fish oil concentrate from North Atlantic fish species containing EPA \u002F DHA \u002F cetoleic acid and gondoic in controlled amounts.",[21,15],null,{"type":26,"name":9,"description":32,"armGroupLabels":33,"otherNames":30},"Corn oil capsules",[15,9],[35],{"facility":36,"status":37,"city":38,"state":30,"zip":30,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Cutest Systems Ltd","RECRUITING","Cardiff","United Kingdom",{"type":41,"coordinates":42},"Point",[43,44],-3.18,51.48,{"lat":44,"lon":43},[47],{"name":48,"role":49,"phone":50,"phoneExt":30,"email":51},"Senior Project Manager Senior Project Manager","CONTACT","+44 2920625686","reception@cutest.co.uk",{"type":53,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR",[55],{"name":36,"class":56},"UNKNOWN","100603204",false,"NCT07133477","A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function","A Randomised, Placebo-Controlled Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function","NEMO","Inclusion Criteria:\n\n* Volunteers who are able to provide signed informed consent\n* Healthy male or female volunteers between the ages of 35 and 65 years\n* Volunteers with a self-perceived history of atopic skin, prone to redness and\u002For dryness\n\nExclusion Criteria:\n\n* Females who are pregnant, breast feeding, or have given birth within the previous 6 weeks or are planning to be pregnant during the study\n* Volunteers with previous experience of intolerance or allergic reactions to fish or fish products\n* Volunteers with an active skin disorder or a significant history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of a trained assessor or dermatologist may affect the test results\n* Volunteers currently taking or who have recently taken antihistamines, antibiotics, systemic anti-inflammatory drugs during the previous week\n* Volunteers currently taking or who have recently taken retinoids, immunosuppressive drugs, anti-cancer drugs during the six previous months\n* Volunteers who have started, stopped or changed hormonal treatment (including contraceptive pills) in the five previous weeks\n* Volunteers whose skin has been exposed to excessive levels of sun or UV rays during the previous month\n* Volunteers who are suffering from chronic asthma, a malfunction of the lymphatic system, or an auto immune deficiency disease (e.g. lupus, thyroiditis)\n* Volunteers with a history of skin tumours or malignant disease\n* Volunteers who have participated in any clinical study involving the test sites within the previous month\n* Volunteers taking fish oil supplements or other lipid-based supplements regularly during the last 4 weeks",true,"ALL","35 Years","65 Years",{"count":69,"type":70},90,"ESTIMATED","INTERVENTIONAL",[73],"NA","The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.\n\nBenefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.",[76],"Skin Health",[78,79,80,81],"skin","mono-unsaturated fatty acids","LCMUFA","omega-3","2025-08-18",{"date":84,"type":85},"2025-08-21","ACTUAL",{"date":87,"type":85},"2025-04-30",{"date":89,"type":70},"2025-12-01",{"name":5,"class":6},1]